Clinical Trial Update: Propofol Injection for Daily Headache [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating propofol injections for chronic daily headache and analgesic rebound headache has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Daily Headache
• Medication-overuse Headache

Drugs mentioned

• DIPRIVAN (Propofol)

Snippet

Sponsor: University of Alberta | Conditions: Chronic Headache, Analgesic Rebound Headache | Phase 2 | Status: COMPLETED